Northwest Biotherapeutics (NWBO) Return on Sales Growth (3y) (2013 - 2026)
Northwest Biotherapeutics (NWBO) Return on Sales Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,440.76 Bn | 66,440.47 Bn | - | - |
| 2 | Nanobiotix | 1,880.51 Bn | 1,880.45 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 467.94 Bn | 463.15 Bn | 1.35 Bn | 1.00 |
| 5 | Vertex Pharmaceuticals | 122.63 Bn | 115.38 Bn | 2.59 Bn | 0.00 |
| 6 | Regeneron Pharmaceuticals | 70.30 Bn | 61.54 Bn | 3.31 Bn | 0.00 |
| 7 | Belite Bio | 62.81 Bn | 62.81 Bn | - | - |
| 8 | Argenx Se | 55.78 Bn | 50.59 Bn | 1.41 Bn | 0.00 |
| 9 | Alnylam Pharmaceuticals | 37.33 Bn | 34.32 Bn | 959.66 Mn | 1.00 |
| 10 | Northwest Biotherapeutics | 275.76 Mn | 273.98 Mn | - | -11.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.00 |
| Dec 31, 2025 | 9.00 |
| Sep 30, 2025 | 548.00 |
| Jun 30, 2025 | -142.00 |
| Mar 31, 2025 | -15.00 |
| Dec 31, 2024 | -56.00 |
| Sep 30, 2024 | -14.00 |
| Jun 30, 2024 | -6.00 |
| Mar 31, 2024 | 27.00 |
| Dec 31, 2023 | 14.00 |
| Sep 30, 2023 | 209.00 |
| Jun 30, 2023 | 4,244.00 |
| Mar 31, 2023 | -1.00 |
| Dec 31, 2022 | -27.00 |
| Sep 30, 2022 | -620.00 |
| Jun 30, 2022 | -34.00 |
| Mar 31, 2022 | -10.00 |
| Dec 31, 2021 | -64.00 |
| Sep 30, 2021 | -9.00 |
| Jun 30, 2021 | 53.00 |